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1. Introduction 
Lipid-protein interactions are of fundamental im- 
portance in the structure of biological membranes 
and of plasma lipoproteins. From previous tudies 
[1-3] it seems reasonable to assume that the inter- 
actions between phospholipids and lipoprotein-pro- 
tein (apoprotein) constituents are fundamental to
the binding of neutral lipid by the plasma lipoproteins. 
For example, there is an insignificant binding of cho- 
lesteryl ester by the apoproteins of human HDL * in 
the absence of phospholipids. We have recently pre- 
sented studies describing the probable location of 
phospholipid-binding site(s) in the MN-glycoprotein 
of the human red cell membrane [4-6] and of 
plasma lipoproteins [7-12]. Phospholipid-binding 
regions do not appear to be uniformly distributed 
along the length of the polypeptide chain [7-11,13] ; 
certain fragments of apoLP-Ala, apoLP-Gln-I and 
apoLP-Gln-II preferentially bind phospholipid as corn- 
* Abbreviations: VLDL, very low density lipoproteins; HDL, 
high density lipoproteins; apoprotein, a lipid-free protein 
component from a lipoprotein; apoLP-Ala nd apoLP-Ser, 
two apoproteins from human VLDL, with carboxyl-termi- 
nal alanine and serine, respectively; apoLP-Gln-I (A-l), and 
apoLP-Gln-II (A-II), the two major apoproteins ofhuman 
HDL, each with carboxyl-terminal glutamine. 
pared to other fragments [7-11 ]. We have found 
that the binding of phospholipid is accompanied by 
circular dichroism changes that are consistent with 
an increase in the a-helical content of the protein or 
peptide [7-11 ]. Under identical conditions, peptide 
fragments hat do not bind phospholipids show no 
changes in circular dichroism. We have therefore re- 
examined the known sequences (fig. 1) of the plasma 
apoproteins [14-16] to determine whether there are 
any structural features which might account for both 
the helical transitions and the binding of phospho- 
lipids. 
Based on our findings, we present anew theory, 
suggesting that the apoproteins contain specific 
amino acid sequences with amphipathic regions that 
can assume the a-helical conformation and which pos- 
sess the following properties: (a) a relatively large 
apolar face which associates with the fatty acid chains 
of phospholipids, and (b) a polar face in which side- 
chains of aspartate, glutamate, lysine and arginine are 
disposed so that negatively charged groups are at the 
center and positively charged groups at the periphery 
of this face. This configuration permits close orienta- 
tion of the zwitterionic polar head_ group zcith the ion 
pairs on the protein. It also allows interaction of the 
carboxyl-terminal portion of the fatty acid chains 
with the hydrophobic face of the helix. Models are 
North-Holland Publishing Company - A msterdam 247 

















I -  






I ¸  ¸~ 
) ~ ~ 
) ~ ~.  




'~ o '~ 
~~ ~o 
248 
Volume 38, number 3 FEBS LETTERS January 1974 
POLAR FACE NON - ROL A l l  FACE 
Apo LP-Ala (VLDL) 
10 
NH z SER GLU ALA GLU ASP ALA SER LEU LEU SER PHE ' - -1 
J 30 2O r GLN GLN ALA ALA VAL GLN GLN SER GLN VAL SER SER LEU ALA ASP LYS ALA THR LYS THR ALA HIS LYS MET TYR GLY GLN MET 
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POLAR FACE NON_POLAR FACE POLAR FACE NON_POLAR FACE 
Apo LP-GIn II (HDL) 
PCA ALA LYS 
~ALA GLN ALA GLN LEU GLU PRO 
, 
GLN LEU THR PRO 
VAL LE GLU THR GLY ALA LYS LYS ILE LEU 
ASN PHE LEU SER TYR PHE VAL GLU LEU GLY THR GLN PRO 
10 
GLU PRO CYS VAL GLU SER LEU VAL SER GLN TYR PHE GLN THR - '7  
/ 
SER ~ 
ALA THR GLN COOH 
(Fig. lc) 
presented to support his amphipathic theory. The 
predicted location of amphipathic helical regions in 
three plasma apoproteins i  consistent with available 
information about he location of phospholipid-bin- 
ding sites in these molecules and their helical content 
as measured by circular dichroism [7-12]. 
2. Experimental 
Helical segments of the apoproteins, apoLP-Ser, 
apoLP-Ala and apoLP-Gln-II were built with Ealing 
CPK-space-fiUing models. A right-handed helical 
backbone with 3.6 residues per turn was constructed. 
For each amphipathic region, amino acid residues 
were added onto the s-carbons in their proper order. 
Specific programs were designed for a computer 
search (J.P. Segrest and R.L. Feldman, unpublished 
results) of all reported amino acid sequences to de- 
termine the following: 1) the frequency of occur- 
rence of amino acid sequences that will generate 
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pOLAR FACE NON _POLAR FACE 
• "'~';":-" 
teins apoLP-Ser, apoLP-Gln-II and apoLP-Ala, 
and the zwitterionic phospholipids, phosphat- 
idylcholine and phosphatidylethanolamine. 
Illustrated is an interaction between two phos- 
phatidylcholine molecules and a portion of the 
amphipathic helical region (residues 57-67) 
from apoLP-Ala (upper figure)• The phosphat- 
idylcholine molecule in the middle figure is 
shown in electrostatic association with the first 
lysyl and first aspartyl residues from the amino- 
terminus of the helix (residues 58 and 59 in 
apoLP-Ala sequence of fig. 1B). The phosphat- 
idylcholine molecule in the lower figure is in e- 
lectrostatic association with the second lysyl 
and first glutamyl residues from the amino-ter- 
minus of the helix (residues 60 and 63). The 
upper helix has been rotated 90 ° to the left of 
its position in the upper figure (polar face) and 
the lower 90 ° to the right• 
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amphipathic helices, and 2) the frequency of occur- 
rence of oppositely charged ion pairs that are in clo- 
se topographic proximity in the amphipathic region. 
It should be noted that such pairs are not necessarily 
adjacent to each other in the linear sequence of the 
molecule. 
3. Results and discussion 
The first structural feature that we wish to point 
out is the relatively frequent occurrence of the apo- 
protein sequences of regions in which charged resi- 
dues are juxtaposed with apolar esidues in a steri- 
cally confined locus, e.g., residues 40-68 of apoLP- 
Ala. We have detected six such sequences in the apo- 
proteins hown in fig. 1. We have constructed space- 
filling models of these regions, making the assump- 
tion that the amino acid residues in these segments 
are in an a-helix. Each a-helix is shown to be amphi- 
pathic, that is, it contains two clearly defined faces, 
one which is polar and the other apolar or hydro- 
phobic. Perutz et al. [ 17 ] have previously observed 
from X-ray crystallography that apolar amino acid 
residues may be buried along the edge of an a-helical 
sequence. An unusual structural feature of the mod- 
el presented here is that the hydrophobic face of 
each helix is not buried along an edge or confined to 
a narrow strip (fig. 2), but rather occupies fully one- 
half of the cylindrical surface of the helix. A compu- 
ter search of all reported amino acid sequences indi- 
cates that amphipathic regions occur in 38 of approx- 
imately 200 different classes of protein (in this anal- 
ysis, proteins uch as cytochromes are defined as a 
class). Highly helical proteins uch as hemoglobin 
and myoglobin do not necessarily contain amphi- 
pathic regions, although the probability of finding 
such a region is theoretically higher in helical pro- 
teins, since amphipathic segments must in general be 
related to an a-helix. 
An important topographic feature of these helices 
is the distribution of charged amino acid residues on 
the polar face of the amphipathic segment. The fre- 
quency of occurrence of oppositely charged side 
chains which are sterically near each other (e.g., 
Glu-44 and Lys-48, of apoLP-Ser, fig. 1), in amphi- 
pathic regions is significantly higher for the three 
apoproteins shown in fig. 1 than for the amphipathic 
regions in other proteins whose sequences have been 
reported. Our computer search indicates atotal of 
76 such ion pairs occur in amphipathic regions of 
proteins of known amino acid sequence. Eighteen 
of these ion pairs occur in the three apoproteins 
shown in fig. 1. 
In addition, the distribution of charged amino acid 
residues on the polar faces is quite striking. The nega- 
tively charged residues, Glu and Asp, invariably oc- 
cur in a narrow strip along the center of the polar 
face, while the positively charged residues, Lys and 
Arg are located on the lateral edge of the polar faces, 
alternating from side to side. In general, the sums of 
the negative and positive residues on each segment of 
a-helix are equal. While members of ion pairs are not 
necessarily adjacent in the primary amino acid se- 
quence, the members of such pairs become topogra- 
phically close when the region is placed in an a-helix. 
There are at least two ion pairs which are not associa- 
ted with an amphipathic helical region, viz., in apoLP- 
Ala, residues 24, 25 and in apoLP-Gln-II, residues 3
and 4. Thus the occurrence of adjacent pairs of zwit- 
terions does not necessarily result in the generation 
of amphipathic helices. There must be juxtaposed in
the amino acid sequence apolar esidues in a sterically 
confined region. As a corollary of this model, the po- 
sitive charged Lys and Arg are at the periphery so 
that their relatively apolar side chains are available 
for hydrophobic nteractions with phospholipids. 
The model for phospholipid-protein interactions 
suggested here is one in which a helical region of the 
apoprotein ishalf-buried at the surface of the phos- 
pholipid structure, such as a micelle. This permits clo- 
se steric contact between acharged amino acid side- 
chain and the oppositely charged groups of the phos- 
pholipid (fig. 2). The long axis of the protein would 
be oriented perpendicular to the hydrocarbon chains 
of the phospholipid x~hich is consistent with X-ray 
diffraction studies of HDL [18, 19]. The non-polar 
face of the helix would be buried in the hydrocarbon 
milieu of the micelle and the polar face exposed to 
the polar ends of the phospholipids as well as to the 
aqueous urroundings. The amphipathic model pre- 
sented here is consistent with binding studies between 
phospholipids and peptide fragments of apoLP-Gln-II 
and apoLP-Ala [7.11,13]. If the degree of hydropho- 
bicity of the nonpolar faces of all amphipathic regions 
selected by the computer search are calculated [6], 
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each of the six regions from the apoproteins shown 
in fig. 1 ranks in the top one-third of the list. Each 
is significantly more hydrophobic than the region of  
the MN-glycoprotein which presumably spans the 
red cell membrane [4-6] .  
It is possible that the occurrence of ion pairs 
along the middle and lateral portions of  the 6 amphi- 
pathic regions of the apoproteins (fig. 1) are related 
to lipid-binding in some manner other than as postu- 
lated here. However, in lieu of further experimental 
data to the contrary, one has to be impressed with 
the topographical fit of this model to the topography 
of the phospholipid molecules. There are several 
other potential important aspects of l ipid-protein 
interaction that are not covered by this theory, inclu- 
ding the effects of adding neutral ipid, lipid-lipid 
interactions and the influence of long range forces 
within an apoprotein. Short helical segments, uch 
as those illustrated in fig. 1 might require stabiliza- 
tion. It seems plausible to assume that there are ad- 
dihonal cooperative and/or long-range ffects neces- 
sary for the phospholipid-binding by the amphipathic 
sequences. In addition, quite different mechanisms of 
l ipid-protein interactions may also be operative. 
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